Dongyao Pharmaceutical-B (01875.HK) achieved a total revenue of 622 million yuan in the first three quarters.

Wisdom Finance and Economics APP news, Dongyao Pharmaceutical-B (01875.HK) announced that for the nine-month period ending on September 30, 2025, the group's operating income was 622 million yuan; the net loss attributable to owners of the company during the period was 3.371 million yuan.